Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Titel:
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Auteur:
Davar, Diwakar Morrison, Robert M. Dzutsev, Amiran K. Karunamurthy, Arivarasan Chauvin, Joe-Marc Amatore, Florent Deutsch, Julie S. Das Neves, Rodrigo X. Rodrigues, Richard R. McCulloch, John A. Wang, Hong Hartman, Douglas J. Badger, Jonathan H. Fernandes, Miriam R. Bai, Yulong Sun, Jie Cole, Alicia M. Aggarwal, Poonam Fang, Jennifer R. Deitrick, Christopher Bao, Riyue Duvvuri, Umamaheswar Sridharan, Shaum S. Kim, Seungwon W. A. Choudry, Haroon Holtzman, Matthew P. Pingpank, James F. O'Toole, James Patrick DeBlasio, Richelle Jin, Yang Ding, Quanquan Gao, Wentao Groetsch, Christopher Pagliano, Ornella Rose, Amy Urban, Corey Singh, Jagjit Divarkar, Prajan Mauro, David Bobilev, Dmitri Wooldridge, James Krieg, Arthur M. Fury, Matthew G. Whiteaker, Jeffrey R. Zhao, Lei Paulovich, Amanda G. Najjar, Yana G. Luke, Jason J. Kirkwood, John M. Taube, Janis M. Park, Hyun Jung Trinchieri, Giorgio Zarour, Hassane M.